The Dark Side of Pharmaceutical Pricing

This chapter explores the complexities of pharmaceutical pricing, focusing on how government and insurance influence drug costs, especially insulin. It critiques unethical corporate practices and the financial burden that high medication prices impose on patients in the U.S. compared to other countries.